Current Medicines
For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs. Our growing portfolio of medicines includes treatments in the areas of cardiovascular, diabetes, men’s health, musculoskeletal, neuroscience and oncology.
Australian laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information about a Lilly product that has been prescribed to them, to speak to their healthcare professional.
The product information on this website is intended for Australian residents, if you are looking for our New Zealand products page, please click here.
Cardiovascular
Adcirca ® (tadalafil)
Cardiovascular – In alliance with Boehringer Ingelheim
Jardiance ® * (empagliflozin)
Dermatology
Taltz ® (ixekizumab)
Olumiant ® (baricitinib)
Diabetes
Humalog ® / Humalog ® Mix25 / Humalog ® Mix50 (insulin lispro) cartridges
Humalog ® / Humalog ® Mix25 / Humalog ® Mix50 (insulin lispro) Kwikpen
Humalog ® (insulin lispro) vials
Humalog ® U200 KwikPen ®
Humulin ® R/ Humulin ® NPH/ Humulin ® 30/70 (biosynthetic human insulin) cartridges
Humulin ® R/Humulin ® NPH/ Humulin ® 30/70 (biosynthetic human insulin) vials
Mounjaro ® (tirzepatide)
Trulicity ® (dulaglutide)
Diabetes – In alliance with Boehringer Ingelheim
Jardiance ® * (empagliflozin)
Jardiamet ® * (empagliflozin / metformin hydrochloride)
Glyxambi ® * (empagliflozin/linagliptin)
* A licensed trademark of Boehringer Ingelheim
Men’s Health
Cialis ® (tadalafil)
Musculoskeletal
Evista ® (raloxifene hydrochloride)
Forteo ® (teriparatide of recombinant DNA origin)
Neuroscience
Cymbalta ® (duloxetine hydrochloride)
Emgality ® (galcanezumab)
Prozac ® (fluoxetine hydrochloride)
Strattera ® (atomoxetine hydrochloride)
Oncology
Alimta ® (pemetrexed)
Cyramza ® (ramucirumab)
Retevmo ® (selpercatinib)
Verzenio TM (abemaciclib)
Rheumatology
Olumiant ® (baricitinib)
Taltz ® (ixekizumab)
PP-MG-AU-0098 05/2024